Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure
Appointed director

Acer Therapeutics Inc. (ACER) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/02/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/03/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/27/2018 SC 13D/A TVM Life Science Ventures VI LP reports a 26.6% stake in Acer Therapeutics Inc.
08/24/2018 SC 13D/A TVM Life Science Ventures VI LP reports a 26.6% stake in Acer Therapeutics Inc.
12/08/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/23/2014 SC 13D/A Zocchi NIcholas J. reports a 4.8% stake in Opexa Theraputics Inc.
08/22/2012 SC 13D/A Albert & Margaret Alkek Foundation reports a 9.6% stake in Opexa Therapeutics, Inc.
12/16/2009 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy